Bacillus Calmette Guerin. Is it necessary to continue with this vaccine;Le BCG. Faut-il continuer à vacciner ?

Archives de Pediatrie

Volumn 11, Issue 8, 2004, Pages 1002-1004

  Begue P ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BCG VACCINATION; DRUG EFFICACY; DRUG INDICATION; FRANCE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HEALTH STATISTICS; HUMAN; INFECTION PREVENTION; POLITICAL SYSTEM; POPULATION MIGRATION; PREVENTIVE MEDICINE; PRIMARY PREVENTION; SHORT SURVEY; SOCIOECONOMICS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 3442894164     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2004.03.018     Document Type: Article

References (11)

1. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a metaanalysis. Int J Epidemiol 1993;22:1154-8.
2. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994;271:698-702.
3. Colditz GA, Berkey CS, Mostella F, Brewer TF, Wilson ME, Bardick E, et al. The efficacy of Bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: metaanalysis of the published litterature. Pediatrics 1995;96:29-35.
4. Gernez-Rieux C, Gervais M. Protection conférée par le BCG pendant les 20 années suivant la vaccination. Bull WHO 1973;48:139-54.
5. Lotte A, Burghard G, Petitjean R, Perdruzen S, Cooreman J, Lert F, et al. Diminution du risque de méningite tuberculeuse chez les enfants en France. Influence de la vaccination par le BCG. Bulletin de l'UICTMR 1988:63-4.
6. Schwoebel V, Hubert B, Grosset J. Impact of BCG on tuberculous meningitis in France in 1990. Lancet 1992;340:611.
7. Cailhol J, Che D, Campese C, Decludt B. Les cas de tuberculose déclarés en France en 2001. BEH 2003;10-11:54-7.
8. Lévy-Bruhl D, Barrault Y, Decludt B, Schwoebel V. BCG et tests tuberculiniques: évolution de la politique vaccinale française. BEH 2003;10-11:61-3.
9. Barrault Y, Decludt B, Lévy-Bruhl D, Schwoebel V. Impact épidémiologique d'une modification de la politique de vaccination par le BCG en France. Institut de la veille sanitaire www.invs.sante.fr.
10. Romanus V, Svensson A, Hallender HO. The impact of changing BCG coverage on tuberculosis incidence in swedish-born children between 1969 and 1989. Tubercle and lung disease 1992;73:150-61.
11. Kelly P, McKeown D, Clancy L. Neonatal BCG vacccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis. Eur Respir J 1997;10:619-23.